3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
8
INDUSTRY
5
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Interferon-alpha
6
Radiosurgery
4
Dacarbazine
4
encorafenib
3
binimetinib
3
aldesleukin
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Cisplatin
3
X-Rays
2
Watchful Waiting
2
Vinblastine
2
Temozolomide
2
Specimen Handling
2
Radiotherapy
2
Polymerase Chain Reaction
2
Observation
2
Nivolumab
2
Ipilimumab
2
Immunologic Techniques
2
Flow Cytometry
2
trametinib
1
sulforaphane
1
sargramostim
1
romidepsin
1
perifosine
1
pembrolizumab
1
peginterferon alfa-2b
1
montanide ISA 51
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Melanoma
×
Immune Checkpoint Inhibitors
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled